Elaia Partners
Investor profile | Builders Republic
About
Elaia is one of the most scientific and "Deeptech" focused Venture Capital firms in Europe. Founded in 2002, it is a historical player that has shifted heavily towards bridging the gap between academic research and business. Elaia differentiates itself by embedding itself directly into the research ecosystem: they have exclusive partnerships with PSL University (Paris Sciences & Lettres) and Inria (National Institute for Research in Digital Science and Technology) to spot innovations before they even leave the lab. While they have a strong digital/SaaS practice, their "superpower" is turning complex science (Quantum, Biotech, AI infrastructure) into global companies.
Key facts
- Type
- Venture Capital
- Stages
- Pre-Seed,Seed,Series A,Series B
- Sectors
- Deeptech,Biotech,Climate / Cleantech / Greentech,Data & Infrastructure,Cyber & Security,AI & Automation,Digital health,Fintech & Insurtech,Future of work / HR,Software / SaaS,Business management software,Life sciences,Healthcare,Quantum
- Headquarters
- France
- Offices
- Paris,Barcelona,Tel Aviv
- Geographic focus
- Europe, France
- Lead / Follow
- Lead / co-lead
- Ticket size
- 0.7M€ – 15M€
- Assets under management
- 850M€
- Founded
- 2002
Track record
- Portfolio companies: 140
- Total investments: 207
- Exits: 46
- Unicorns: 3
Notable investments in France
Criteo, Mirakl, Ornikar, Shift Technology, Alice & Bob, Aquemia, Ibanfirst, Sonio, ...
Key differentiators
Strong Track Record,Deeptech Specialist,Multi-stage,Corporate-backed